According to the results of this study, HSP60 alone has relevance as a predictor of prognosis at the late/advanced stages, and the higher the HSP60, the better the prognosis, indicating it acts as an ‘anti-tumor marker’. This evidence concerns the gene HSPD1 and neoplasm.